Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial by Kordes, Sil, MD, Pollak, Michael N, Prof, Zwinderman, Aeilko H, Prof, Mathôt, Ron A, PhD, Weterman, Mariëtte J, Beeker, Aart, MD, Punt, Cornelis J, Prof, Richel, Dick J, Prof, Wilmink, Johanna W, Dr

Get full text

Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease by ter Veer, Emil, MSc, van Rijssen, L Bengt, MD, Besselink, Marc G, Prof, Mali, Rosa M A, BSc, Berlin, Jordan D, Prof, Boeck, Stefan, Prof, Bonnetain, Franck, Prof, Chau, Ian, MD, Conroy, Thierry, Prof, Van Cutsem, Eric, Prof, Deplanque, Gael, MD, Friess, Helmut, Prof, Glimelius, Bengt, Prof, Goldstein, David, Prof, Herrmann, Richard, Prof, Labianca, Roberto, MD, Van Laethem, Jean-Luc, Prof, Macarulla, Teresa, MD, van der Meer, Jonathan H M, MD, Neoptolemos, John P, Prof, Okusaka, Takuji, MD, O'Reilly, Eileen M, Prof, Pelzer, Uwe, MD, Philip, Philip A, Prof, van der Poel, Marcel J, MD, Reni, Michele, MD, Scheithauer, Werner, Prof, Siveke, Jens T, Prof, Verslype, Chris, Prof, Busch, Olivier R, Prof, Wilmink, Johanna W, MD, van Oijen, Martijn G H, PhD, van Laarhoven, Hanneke W M, Prof

Get full text